You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'recombinant'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 16 KDa. Observed: 15-21 KDa, reducing conditions
Human
Gly32-Leu153
C-6His-Avi
20 μg, 100 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 25.5 KDa. Observed: 26-38 KDa, reducing conditions
Rhesus macaque
Leu72-Leu251
N-6His-Flag
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified). SEC-HPLC: Greater than 95% as determined by SEC-HPLC.(QC verified)
Predicted: 14.3 KDa. Observed: 17-30 KDa, reducing conditions
Human
Arg22-Gln138
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 46.5 KDa. Observed: 50-65 KDa, reducing conditions
Human
Leu72-Leu251
N-mFc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by SDS-PAGE. (QC verified). SEC-HPLC: Greater than 95% as determined by SEC-HPLC.(QC verified)
Predicted: 70.9 KDa. Observed: 77-99 KDa, reducing conditions
Human
Asp21-Thr416
C-hFc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by SDS-PAGE. (QC verified)
Predicted: 20.1 KDa. Observed: 25-36 KDa, reducing conditions
Human
Gln67-Ser225
C-6His
10 μg, 50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 24.9 KDa. Observed: 27-42 KDa
Cynomolgus
Ala27-Arg 242
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 49.1 KDa. Observed: 48-58 KDa, reducing conditions
Human
(SLLMWITQV)(Cys165Val)&Ile21-Met119&Gly25-Ile308(Ala269Val)
C-10His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 49.1 KDa. Observed: 50-60 KDa, reducing conditions
Human
(FVGEFFTDV)&Ile21-Met119&Gly25-Ile308(Ala269Val)
C-10His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 51 KDa. Observed: 50-61 KDa, reducing conditions
Human
(YLEPGPVTV)(Ala288Val)&Ile21-Met119&Gly25-Ile308(Ala269Val)
C-10His
1 mg, 10 μg, 50 μg, 500 μg